U.S. Patent and Trademark Office (PTO) NOTICE OF ALLOWANCE |
ISSUE DATE OF NOA: Apr 22, 2003
JOHN CLARKE HOLMAN JACOBSON HOLMAN PLLC THE JENIFER BUILDING, 400 SEVENTH ST NW WASHINGTON, D.C. 20004-2201 |
ATTORNEY REFERENCE NUMBER T33202USO |
** IMPORTANT INFORMATION: 6 MONTH DEADLINE ** Please note that both the "Statement of Use " and "Extension Request" have many legal requirements, including fees. These requirements are explained in the PTO booklet "Basic Facts About Trademarks", which can be obtained upon request at (703)308-9000. In addition, there are printed forms contained in this booklet (for "Statement of Use" and "Extension Requests") for your use. |
The following information should be reviewed for accuracy:
SERIAL NUMBER: | 76/389834 |
MARK: | PROLON |
OWNER: | Schwarz Pharma AG |
Alfred-Nobel-Strasse 10 D-40789 Monheim , FED REP GERMANY |
Section 1(a): NO | Section 1(b): YES | Section 44(e): YES |
GOODS/SERVICES BY INTERNATIONAL CLASS
005 - | Pharmaceutical preparations for the treatment of urological diseases, central nervous system diseases, heart and circulatory diseases sold by prescription only |
ALL OF THE GOODS/SERVICES IN EACH CLASS ARE LISTED
ADDITIONAL INFORMATION MAY BE PRESENT IN THE PTO RECORDS